ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,425.38
      -0.11%
      US Tech 100
      19,170.00
      0.01%
      Dow Jones
      38,513.76
      -0.20%
      Brent Oil
      82.865
      0.90%
      Bitcoin
      65,325.94
      -1.97%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Clarus Therapeutics Holdings Inc (CRXT)

      7. Clarus Therapeutics Holdings Inc (CRXT) News

      CRXT

      Clarus Therapeutics (CRXT)

      Clarus Therapeutics Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CRXT
      DateTimeSourceHeadlineSymbolCompany
      03/07/20236:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      03/01/20237:36AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      03/01/20237:23AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      03/01/20237:20AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      03/01/20237:17AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      03/01/20237:07AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      02/22/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      01/24/20234:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      12/22/20224:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      11/23/20226:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      10/18/20224:05PMGlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful BidderNASDAQ:CRXTClarus Therapeutics Holdings Inc
      09/14/20229:52AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      09/05/202210:19PMGlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy CodeNASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/26/20224:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/26/20224:33PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/26/20224:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/26/20224:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/22/202212:05PMTipRanksClarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at NeedhamNASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/19/20226:38AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/19/20226:34AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/19/20226:32AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/19/20226:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/18/20224:50PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/18/20224:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/18/20224:05PMGlobeNewswire Inc.Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce ReductionNASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/10/20226:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/10/20226:05AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      08/09/20225:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      07/28/20229:05AMGlobeNewswire Inc.Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)NASDAQ:CRXTClarus Therapeutics Holdings Inc
      07/06/20224:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRXTClarus Therapeutics Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:CRXT